---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-044181"
form_type: "8-K"
ticker: "CC"
cik: "0001627223"
company_name: "Chemours Co"
filed_at: "2023-08-23T23:59:59+00:00"
generated_at: "2026-06-11T04:50:18.976556+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Chemours completes $2.97B credit amendment with $900M revolver, $1.07B and €415M term loans

## Summary
- Refinances existing term loans via $1.07B Tranche B-3 US$ Term Loan (SOFR+3.5%, floor 0.5%) and €415M Tranche B-3 Euro Term Loan (EURIBOR+4%, floor 0%).
- New $900M revolving credit facility matures Oct 7, 2026; term loans mature Aug 18, 2028.
- Proceeds used to refinance existing facilities (including cashless conversion), pay fees, and for working capital.
- Covenants amended for increased flexibility; obligations secured by first-priority liens on assets of Chemours and domestic subsidiaries.
- Senior secured facilities guaranteed by material domestic subsidiaries with 100% of domestic and 65% of foreign subsidiary stock pledged.

## SEC filing metadata
- accession: 0000950170-23-044181
- form_type: 8-K
- ticker: CC
- cik: 0001627223
- company_name: Chemours Co
- filed_at: 2023-08-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1627223/000095017023044181/0000950170-23-044181-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1627223/000095017023044181/cc-20230818.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-044181
- JSON: https://secwatch.observer/filing/0000950170-23-044181.json
- Plain text: https://secwatch.observer/filing/0000950170-23-044181.txt

## Key facts
- Debt Financings
  Chemours Co incurred term loan of €415,000,000 with JPMorgan Chase Bank, N.A., as administrative agent at adjusted EURIBOR plus 4.00%, subject to an adjusted EURIBOR floor of 0.0% maturing August 18, 2028.
  - Instrument: term loan
  - Principal: €415,000,000
  - Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
  - Rate: adjusted EURIBOR plus 4.00%, subject to an adjusted EURIBOR floor of 0.0%
  - Maturity: August 18, 2028
  - Event: incurrence
  source text: principal amount equal to $1,070,000,000 (the “Term Loan B-3 US$ Facility”), and a five-year senior secured term loan facility in an aggregate principal amount equal to €415,000,000 (the “Term Loan B-3 Euro Facility”). The Term Loan B-3 US$ Facility and the Term Loan B-3 Euro Facility are referred to collectively as the “New Term Loan Facilities.” The Tranche
  evidence_url: https://www.sec.gov/Archives/edgar/data/1627223/000095017023044181/0000950170-23-044181-index.htm
- Debt Financings
  Chemours Co incurred term loan of $1,070,000,000 with JPMorgan Chase Bank, N.A., as administrative agent at adjusted Term SOFR plus 3.50%, subject to an adjusted SOFR floor of 0.50%, or ad maturing August 18, 2028.
  - Instrument: term loan
  - Principal: $1,070,000,000
  - Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
  - Rate: adjusted Term SOFR plus 3.50%, subject to an adjusted SOFR floor of 0.50%, or ad
  - Maturity: August 18, 2028
  - Event: incurrence
  source text: commitments in an amount equal to $900,000,000 (the “Revolving Credit Facility”), a five-year, senior secured term loan facility in an aggregate principal amount equal to $1,070,000,000 (the “Term Loan B-3 US$ Facility”), and a five-year senior secured term loan facility in an aggregate principal amount equal to €415,000,000 (the “Term Loan B-3 Euro Facility”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1627223/000095017023044181/0000950170-23-044181-index.htm
- Debt Financings
  Chemours Co incurred revolving credit of $900,000,000 with JPMorgan Chase Bank, N.A., as administrative agent maturing October 7, 2026.
  - Instrument: revolving credit
  - Principal: $900,000,000
  - Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
  - Maturity: October 7, 2026
  - Event: incurrence
  source text: The Restatement Agreement provides for a senior secured revolving credit facility with aggregate commitments in an amount equal to $900,000,000 (the “Revolving Credit Facility”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1627223/000095017023044181/0000950170-23-044181-index.htm
- Material Agreements
  Chemours Co entered into Amendment and Restatement Agreement with JPMorgan Chase Bank, N.A. valued at $900,000,000, $1,070,000,000, €415,000,000 (effective 2023-08-18).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: JPMorgan Chase Bank, N.A.
  - Value: $900,000,000, $1,070,000,000, €415,000,000
  - Effective: 2023-08-18
  source text: On August 18, 2023, The Chemours Company (the “Company”) entered into an Amendment and Restatement Agreement (the “Restatement Agreement”) among the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent, which amends and restates in its entirety the Amended and Restated Credit Agreement, dated as of April 3, 2018
  evidence_url: https://www.sec.gov/Archives/edgar/data/1627223/000095017023044181/0000950170-23-044181-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.